Results 1 to 10 of about 644,370 (183)

Synthesis and In Vitro Evaluation of Anticancer Activity of Fluorophenyl Derivatives of 1,3,4-Thiadiazole Against Estrogen-Dependent Breast Cancer

Molecules
Breast cancer remains the most frequently diagnosed malignant tumor among women worldwide, and the limited selectivity as well as the emerging resistance to currently used therapies highlight the need to search for new therapeutic compounds. Aromatase, a
Sara Janowska, Anna Makuch-Kocka, Rafał Kurczab, Oleg M. Demchuk, Monika Wujec   +4 more
doaj   +1 more source

Computational drug designing of fungal pigments as potential aromatase inhibitors

Bangladesh Journal of Pharmacology, 2014
The existing aromatase inhibitors produced unwelcome effects impose the discovery of novel drugs with privileged selectivity, a reduced amount of toxicity and humanizing potency.
Nighat Fatima, Abida Kalsoom, Amara Mumtaz, Syed Aun Muhammad   +3 more
doaj  

Impact of endocrine therapy regimens for early-stage ER+/HER2- breast cancer on contralateral breast cancer risk

npj Breast Cancer
Endocrine therapy for breast cancer may reduce the risk of contralateral breast cancer (CBC). However, there are no published estimates quantifying the lifetime outcomes by age at primary diagnosis, regimen, or duration.
Swarnavo Sarkar, Clyde Schechter, Allison W. Kurian, Jennifer L. Caswell-Jin, Jinani Jayasekera, Jeanne S. Mandelblatt   +5 more
doaj   +1 more source

EVALUATION OF LETROZOLE THERAPEUTIC EFFECT IN INFERTILE WOMEN

Acta Medica Iranica, 2007
Combination therapy with clomiphene citrate plus gonadotropin (clomiphene citrate plus HMG) in induction ovulation reduce the gonadotropins dose but antiestrogenic effect of c.c. can decrease pregnancy rate.
F. Akbary-Asbagh, Z. Heidar, F. Frozan-Fard, K. Nouri, O. Azmodeh, A. Ghasemynejad, N. Salsabily M. Amirian   +6 more
doaj  

History of the early development of aromatase inhibitors for treatment of breast cancer. [PDF]

Breast Cancer Res Treat
Santen RJ, Demers LM.
europepmc   +1 more source

Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment? [PDF]

Breast Cancer Res Treat
Dabour MS, Shaaban A, Duprez DA, Zordoky BN, Blaes AH.   +4 more
europepmc   +1 more source

Aromatase inhibitors

Journal of Synthetic Organic Chemistry, Japan, 1988
HIRSCH KENNETH S, JONES CHARLES D, TAYLOR HAROLD M   +2 more
openaire   +4 more sources

Developing Mixed Micelle Delivery Systems for Aromatase Inhibitors. [PDF]

ACS Omega
Vermani S, Singh P, Kaur V, Bedi N, Jaglan S, Kaur S, Ahmad SS.   +6 more
europepmc   +1 more source

Near Final Height in Males treated with Aromatase Inhibitors [PDF]

J Clin Res Pediatr Endocrinol
Bouliari A, An A, Lekarev O, Lin-Su K.
europepmc   +1 more source

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors-the PAC-WOMAN trial. [PDF]

Front Pain Res (Lausanne)
Nobre I, Silva MN, Franco S, Rodrigues B, Silva PF, Teixeira PJ, Carraça EV.   +6 more
europepmc   +1 more source